STOCK TITAN
  1. Home
  2. Sec-filings
  3. DTIL
  4. [EFFECT] PRECISION BIOSCIENCES INC SEC Filing

[EFFECT] PRECISION BIOSCIENCES INC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 7, 2026 4:05 P.M.
Form: S-3
CIK: 0001357874
Company Name: PRECISION BIOSCIENCES INC
File Number: 333-292478

Source: View Original Filing on SEC EDGAR

Stock DTIL logo
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

#5037 Ranked by Market Cap
N/A Ranked by Dividends

DTIL Latest News

Jan 12, 2026
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
Jan 7, 2026
iECURE Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ECUR-506 for Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
Dec 23, 2025
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Nov 19, 2025
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025
Nov 10, 2025
Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants

DTIL Latest SEC Filings

Dec 17, 2025
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity
Dec 17, 2025
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity
Dec 17, 2025
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity
Nov 12, 2025
[8-K] PRECISION BIOSCIENCES INC Reports Material Event
Nov 12, 2025
[424B5] PRECISION BIOSCIENCES INC Prospectus Supplement (Debt Securities)

DTIL Stock Data

97.73M
22.56M
11.28%
44.24%
9.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM